Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ekaterina B Likold"'
Autor:
Bella V. Biderman, Ekaterina B. Likold, Nataliya A. Severina, Tatiana N. Obukhova, Andrey B. Sudarikov
Publikováno v:
Genes
Volume 14
Issue 2
Pages: 532
Volume 14
Issue 2
Pages: 532
Chronic lymphocytic leukemia (CLL) is one of the most common B-cell malignancies in Western countries. IGHV mutational status is the most important prognostic factor for this disease. CLL is characterized by an extreme narrowing of the IGHV genes rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce205470a276a06698f72d79b4337ac0
Autor:
Eugene Nikitin, Darya A. Koroleva, E E Zvonkov, Ekaterina B Likold, B V Biderman, Al'-Radi Ls, Hunan Julhakyan, Andrey Sudarikov, Svetlana Smirnova
Publikováno v:
Clinical lymphoma, myelomaleukemia. 21(12)
Introduction Immunoglobulin heavy chain variable region (IGHV) repertoire narrowing could be an evidence for the involvement of a limited set of antigens in the development of lymphomas. For chronic lymphocytic leukemia (CLL) the existence of more th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba509ec84d1fc073bd5c1fa73613b46b
https://pubmed.ncbi.nlm.nih.gov/34384734
https://pubmed.ncbi.nlm.nih.gov/34384734
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S321
Background: Mutational status of the IGHV genes and B-cell receptor stereotype are the key prognostic factors for CLL. However, the routinely used Sanger sequencing technique may fail for cases with an expansion of more than one tumor B-cell clones,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3a3694ffbb4c4258fa7b0ff5229c914
https://doi.org/10.1016/s2152-2650(21)01755-9
https://doi.org/10.1016/s2152-2650(21)01755-9
Autor:
Ekaterina B Likold, Tatiana N. Obukhova, Andrey Sudarikov, V G Savchenko, Nataliya A. Severina, B V Biderman
Publikováno v:
Blood. 136:16-17
Background: The features of the IGHV gene repertoire in CLL have been widely discussed in the last 20 years. In approximately 30% of cases of CLL, highly homologous "stereotyped" antigen receptors (SARs) are expressed, representing quasi identical am
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89c1ef420d22117c63bd924b5399db9f
https://doi.org/10.1182/blood-2020-140663
https://doi.org/10.1182/blood-2020-140663
Autor:
Andrey Sudarikov, Natalya Severina, Hunan Julhakyan, Ekaterina B Likold, B V Biderman, T N Obukhova
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S226
Background About 30% of cases of CLL express highly homologous “stereotype” antigenic receptors (SARs) which can be assigned to different subsets. Several SARs have already been identified as independent prognostic factors for CLL (CLL#1, CLL#2,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2060138b3ed6d101c0e2709e83092b17
https://doi.org/10.1016/s2152-2650(20)30799-0
https://doi.org/10.1016/s2152-2650(20)30799-0